Clinical trial
Chronotherapy with Low-dose Aspirin for Primary Prevention of Cardiovascular Events in Subjects with Impaired Fasting Glucose or Diabetes (CARING Study).
NCT00725127 is registered in ClinicalTrials.gov with University of Vigo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chronotherapy with Low-dose Aspirin for Primary Prevention of Cardiovascular Events in Subjects with Impaired Fasting Glucose or Diabetes (CARING Study).
- Lead sponsor
- University of Vigo
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- October 31, 2008
- Completion date
- June 30, 2026
- Enrollment
- 3,200 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes